Cardiomyocyte remodelling during myocardial hibernation and atrial fibrillation: Prelude to apoptosis

Cardiovascular Research

Volumn 43, Issue 4, 1999, Pages 947-957

  Dispersyn, Gerrit D ^a   Ausma, Jannie ^a   Thoné, Fred ^b   Flameng, Willem ^c   Vanoverschelde, Jean Louis J ^d   Allessie, Maurits A ^a   Ramaekers, Frans C S ^a   Borgers, Marcel ^a,b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b JANSSEN RESEARCH FOUNDATION   (Belgium)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d UNIVERSITY OF LOUVAIN MEDICAL SCHOOL   (Belgium)

Author keywords

Apoptosis; Atrial function; Hibernation; Histopathology; Remodelling

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CHROMATIN; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DAMAGE; ELECTRON MICROSCOPY; FEMALE; FROZEN SECTION; GOAT; HEART ATRIUM FIBRILLATION; HEART VENTRICLE REMODELING; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MORPHOLOGY; MYOCARDIAL HIBERNATION; PATIENT SELECTION; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; ATRIAL FIBRILLATION; BIOLOGICAL MARKERS; FEMALE; GOATS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MICROSCOPY, ELECTRON; MYOCARDIAL STUNNING; MYOCARDIUM; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032827061     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(99)00096-6     Document Type: Article

References (48)

1. Rahimtoola S.H. The hibernating myocardium. Am Heart J. 117:1989;211-221.
2. Rahimtoola S.H. Hibernating myocardium: a brief article. Basic Res Cardiol. 90:1995;38-40.
3. Borgers M., Thoné F., Wouters L., et al. Structural correlates of regional myocardial dysfunction in patients with critical coronary artery stenosis: chronic hibernation? Cardiovasc Pathol. 2:1993;237-245.
4. Ausma J., Schaart G., Thoné F., et al. Chronic ischemic viable myocardium in man: aspects of dedifferentiation. Cardiovasc Pathol. 4:1995;29-37.
5. Wijffels M.C., Kirchhof C.J., Dorland R., Allessie M.A. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation. 92:1995;1954-1968.
6. Ausma J., Wijffels M., Thoné F., et al. Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat. Circulation. 96:1997;3157-3163.
7. Ausma J., Wijffels M., van Eys G., et al. Dedifferentiation of atrial cardiomyocytes as a result of chronic atrial fibrillation. Am J Pathol. 151:1997;985-997.
8. Borgers M., De Nollin S., Thoné F., et al. Distribution of calcium in a subset of chronic hibernating myocardium in man. Histochem J. 25:1993;312-318.
9. Ausma J., Thoné F., Dispersyn G.D., et al. Dedifferentiated cardiomyocytes from chronic hibernating myocardium are not ischemic. Mol Cell Biochem. 186:1998;159-168.
10. Schwarz E.R., Schaper J., vom Dahl J., et al. Myocyte degeneration and cell death in hibernating human myocardium. J Am Coll Cardiol. 27:1996;1577-1585.
11. Chen C., Ma L., Linfert D.R., et al. Myocardial cell death and apoptosis in hibernating myocardium. J Am Coll Cardiol. 30:1997;1407-1412.
12. Elsässer A., Schlepper M., Klövekorn W., et al. Hibernating myocardium: an incomplete adaptation to ischemia. Circulation. 96:1997;2920-2931.
13. Kerr J.F., Wyllie A.H., Currie A.R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 26:1972;239-257.
14. Hockenbery D., Nunez G., Milliman C., Schreiber R.D., Korsmeyer S.J. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature. 348:1990;334-336.
15. Lane D.P. Cancer. p53, guardian of the genome. Nature. 358:1992;15-16.
16. Wyllie A.H., Morris R.G., Smith A.L., Dunlop D. Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis. J Pathol. 142:1984;67-77.
17. James T.N. Normal and abnormal consequences of apoptosis in the human heart. From postnatal morphogenesis to paroxysmal arrhythmias. Circulation. 90:1994;556-573.
18. Kajstura J., Mansukhani M., Cheng W., et al. Programmed cell death and expression of the protooncogene bcl-2 in myocytes during postnatal maturation of the heart. Exp Cell Res. 219:1995;110-121.
19. Cheng W., Kajstura J., Nitahara J.A., et al. Programmed myocyte cell death affects the viable myocardium after infarction in rats. Exp Cell Res. 226:1996;316-327.
20. Kajstura J., Cheng W., Sarangarajan R., et al. Necrotic and apoptotic myocyte cell death in the aging heart of Fischer 344 rats. Am J Physiol. 271:1996;H1215-H1228.
21. Itoh G., Tamura J., Suzuki M., et al. DNA fragmentation of human infarcted myocardial cells demonstrated by the nick end labeling method and DNA agarose gel electrophoresis. Am J Pathol. 146:1995;1325-1331.
22. Saraste A., Pulkki K., Kallajoki M., et al. Apoptosis in human acute myocardial infarction. Circulation. 95:1997;320-323.
23. Sharov V.G., Sabbah H.N., Shimoyama H., et al. Evidence of cardiocyte apoptosis in myocardium of dogs with chronic heart failure. Am J Pathol. 148:1996;141-149.
24. Yao M., Keogh A., Spratt P., dos Remedios C.G., Kiessling P.C. Elevated DNase I levels in human idiopathic dilated cardiomyopathy: an indicator of apoptosis? J Mol Cell Cardiol. 28:1996;95-101.
25. Mallat Z., Tedgui A., Fontaliran F., et al. Evidence of apoptosis in arrhythmogenic right ventricular dysplasia. N Engl J Med. 335:1996;1190-1196.
26. Narula J., Haider N., Virmani R., et al. Apoptosis in myocytes in end-stage heart failure. N Engl J Med. 335:1996;1182-1189.
27. Flameng W., Wouters L., Sergeant P., et al. Multivariate analysis of angiographic, histologic, and electrocardiographic data in patients with coronary heart disease. Circulation. 70:1984;7-17.
28. Vanoverschelde J.L., Wijns W., Depré C., et al. Mechanisms of chronic regional postischemic dysfunction in humans. New insights from the study of noninfarcted collateral-dependent myocardium. Circulation. 87:1993;1513-1523.
29. Maes A., Flameng W., Nuyts J., et al. Histological alterations in chronically hypoperfused myocardium. Correlation with PET findings. Circulation. 90:1994;735-745.
30. Gavrieli Y., Sherman Y., Ben-Sasson S.A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol. 119:1992;493-501.
31. Jansen M.P.H.M., Machiels B.M., Hopman A.H.N., et al. Comparison of A- and B-type lamin expression in reactive lymph nodes and nodular sclerosing Hodgkins-disease. Histopathology. 31:1997;304-312.
32. Krekels G., Voorter C., Kuik F., Verhaegh M., Ramaekers F., Neumann M. DNA-protection by sunscreens - p53 immunostaining. Eur J Dermatol. 7:1997;259-262.
33. Hockenbery D.M., Zutter M., Hickey W., Nahm M., Korsmeyer S.J. BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci USA. 88:1991;6961-6965.
34. McDonnell T.J., Beham A., Sarkiss M., Andersen M.M., Lo P. Importance of the Bcl-2 family in cell death regulation. Experientia. 52:1996;1008-1017.
35. Misao J., Hayakawa Y., Ohno M., et al. Expression of bcl-2 protein, an inhibitor of apoptosis, and Bax, an accelerator of apoptosis, in ventricular myocytes of human hearts with myocardial infarction. Circulation. 94:1996;1506-1512.
36. Olivetti G., Abbi R., Quani F., et al. Apoptosis in the failing human heart. N Engl J Med. 336:1997;1131-1141.
37. Anversa P., Olivetti G., Leri A., Liu Y., Kajstura J. Myocyte cell death and ventricular remodeling. Curr Opin Nephrol Hypertens. 6:1997;169-176.
38. Kim K.K., Soonpaa M.H., Daud A.I., et al. Tumor suppressor gene expression during normal and pathologic myocardial growth. J Biol Chem. 269:1994;22607-22613.
39. Nees M., Homann N., Discher H., et al. Expression of mutated p53 occurs in tumor-distant epithelia of head and neck cancer patients: a possible molecular basis for the development of multiple tumors. Cancer Res. 53:1993;4189-4196.
40. Savio M., Stivala L.A., Bianchi L., Vannini V., Prosperi E. Involvement of the proliferating cell nuclear antigen (PCNA) in DNA repair induced by alkylating agents and oxidative damage in human fibroblasts. Carcinogenesis. 19:1998;591-596.
41. Berges R.R., Furuya Y., Remington L., et al. Cell proliferation, DNA repair, and p53 function are not required for programmed death of prostatic glandular cells induced by androgen ablation. Proc Natl Acad Sci USA. 90:1993;8910-8914.
42. Hall P.A., Levison D.A., Woods A.L., et al. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol. 162:1990;285-294.
43. Matturri L., Biondo B., Colombo B., Lavezzi A.M., Rossi L. Significance of the DNA synthesis in hypertrophic cardiomyopathies. Basic Res Cardiol. 92:1997;85-89.
44. Marino T.A., Cao W., Lee J., Courtney R. Localization of proliferating cell nuclear antigen in the developing and mature rat heart cell. Anat Rec. 245:1996;677-684.
45. Colucci W.S.C. Apoptosis in the heart. N Engl J Med. 335:1996;1224-1226.
46. Allen R.T., Hunter W.J., Agrawal D.K. Morphological and biochemical characterization and analysis of apoptosis. J Pharmacol Toxicol Methods. 37:1997;215-228.
47. Collins R.J., Harmon B.V., Gobe G.C., Kerr J.F. Internucleosomal DNA cleavage should not be the sole criterion for identifying apoptosis. Int J Radiat Biol. 61:1992;451-453.
48. Wasseem N.H., Lane D.P. Monoclonal antibody analysis of the fission yeast gene encoding polymerase δ accessory protein PCNA. J Cell Sci. 96:1990;121-129.